Get started
Author

Benjamin Wipper

Observed names: B. Wipper, Wipper B
ORCID: 0000-0002-3143-5627
Observed ORCID: 0000-0002-3143-5627
OpenAlex ID: A5087663385
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study
2023 · Karol Mateusz Pencina, Rodrigo Valderrabano, et al. · The Journal of Clinical Endocrinology & Metabolism · 47
PDF
The Long-Term Psychiatric and Cardiovascular Morbidity and Mortality of Restless Legs Syndrome and Periodic Limb Movements of Sleep
2021 · Benjamin Wipper, John W. Winkelman · Sleep Medicine Clinics · 32
Topiramate reduces nocturnal eating in sleep-related eating disorder
2020 · John W Winkelman, Benjamin Wipper, et al. · SLEEP · 32
Restless Legs Syndrome: A Review.
2026 · John W Winkelman, Benjamin Wipper · PubMed · 30
Long-term Safety, Dose Stability, and Efficacy of Opioids for Patients With Restless Legs Syndrome in the National RLS Opioid Registry
2023 · John Weyl Winkelman, Benjamin Wipper, et al. · Neurology · 27
PDF
Baseline and 1-year longitudinal data from the National Restless Legs Syndrome Opioid Registry
2020 · John W Winkelman, Julia Purks, et al. · SLEEP · 24
Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic
2022 · Benjamin Wipper, Christopher Romero-Gutierrez, et al. · Sleep Medicine · 12
Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID ‐19
2024 · Rodrigo J. Valderrábano, Benjamin Wipper, et al. · Aging Cell · 10
PDF
Relationship of Suboptimal and Disordered Sleep with Cardiovascular Disease and Its Risk Factors – A Narrative Review
2024 · Benjamin Wipper, Lukas Mayer-Suess, et al. · Neuroepidemiology · 7
PDF
Effectiveness and dose stability of opioids in patients with restless leg syndrome: 5-year findings from the National Restless Legs Syndrome Opioid Registry
2026 · John W Winkelman, Adysn Kilty, et al. · SLEEP · 5
Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder
2023 · Benjamin Wipper, Michelle Cooke, et al. · Nature and Science of Sleep · 5
PDF
0904 Five-Year Outcomes from the National RLS Opioid Registry: Efficacy, Stability, and Tolerability
2025 · John Winkelman, Adysn Kilty, et al. · SLEEP · 3
PDF
Lack of Efficacy of Suvorexant in People with Insomnia and Poorly Controlled Type 2 Diabetes
2023 · John Winkelman, Benjamin Wipper, et al. · Nature and Science of Sleep · 2
PDF
Rwandan man with a case of the blues
2024 · Benjamin Wipper, Hanna Blaney, et al. · Frontline Gastroenterology · 1
Developing Global Gastrointestinal Care Capacity
2025 · Matthew R. Bryan, Gordon P. Bensen, et al. · Journal of Clinical Gastroenterology
0684 National RLS Opioid Registry: Four-year Dose Stability, Efficacy and Tolerability
2024 · John Winkelman, Jordana Zackon, et al. · SLEEP
PDF
National RLS Opioid Registry: three-year safety, dose stability, and efficacy
2024 · J. Winkelman, J. Zackon, et al. · Sleep Medicine
0398 Efficacy of Suvorexant for Insomnia Disorder in Patients with Poorly-Controlled Type 2 Diabetes
2023 · John Winkelman, Benjamin Wipper, et al. · SLEEP
PDF
532 Two-Year Longitudinal Data From the National Restless Legs Syndrome Opioid Registry
2021 · John Winkelman, Benjamin Wipper, et al. · SLEEP
530 Restless Legs Syndrome Prevalence and Severity Among Patients Treated with Buprenorphine and Naloxone for Opioid Use Disorder
2021 · Benjamin Wipper, Michelle Cooke, et al. · SLEEP
Works count: 21
Citation count: 237
H-index: 8
I10-index: 8
Year
Topic
Type